Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Breast cancer

17.02.2026

Cancer needs energy to move

12.01.2026

VIOLET Pharmaceuticals, a new spin-off using mRNA to further immunotherapy against cancer

14.07.2025

A new target to prevent metastasis before it manifests itself

07.04.2025

Breast cancer cells through your mobile

Carmen Moccia, first author of the work, holding one of the devices used to generate vascularized mammary tissues.
09.07.2024

How do sex hormones affect breast microvessels?

02.12.2022

A model to predict individual breast cancer risk

03.10.2022

A faster way to visualise breast lesions during a biopsy

30.03.2022

Big push for immunotherapy against the most aggressive type of breast cancer

17.09.2021

Potential way to prevent resistance to treatment for one of the most aggressive breast cancers

Toni Celià Terrassa is the protagonist of the fifth episode of the PRBB's scientific dissemination podcast in Catalan.
02.09.2021

Toni Celià Terrassa (IMIM): “In science you need a lot of luck, and you need to persevere and look for it”

29.04.2021

Dora Romaguera (ISGlobal): “One of the main problems with ultra-processed foods is that they displace the consumption of healthy foods”

13.04.2021

A breast cancer risk prediction model for more personalized screening

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2026 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org